Answers are grounded in this paper and cite their sources.
Helicobacter pylori infection has been associated with small intestinal bacterial overgrowth (SIBO), but the mechanisms underlying this relationship remain uncertain. This article aims to propose a phenotype-based dual-pathway hypothesis explaining how H. pylori may contribute to SIBO through distinct but overlapping biological mechanisms. In the preserved-acid pathway, virulence-associated inflammatory signaling may theoretically impair enteric neuromuscular function, migrating motor complex activity and epithelial barrier integrity, although direct human evidence remains limited. In the atrophy–hypochlorhydria pathway, corpus-predominant atrophic gastritis may weaken the gastric acid barrier, increase gastric and proximal small-intestinal microbial burden, and facilitate downstream microbial expansion. A mixed phenotype may arise when partial atrophy, inflammation, proton pump inhibitor exposure, dysmotility and relevant comorbidities coexist. This framework treats chronological age as an imperfect surrogate for gastric phenotype, acid-secretory status, virulence profile, medication exposure and motility reserve. If validated, phenotype-based stratification could improve the design of future studies and support a more individualized evaluation of patients with concomitant H. pylori infection and suspected SIBO.
No takes yet. Share an insight, caveat, or question.
Betoret et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: